Observing Effects of Daily Personalized Digital Reminiscence Therapy Using a Conversational Agent in Older Adults with Mild Neurocognitive Disorders

What this Trial Is About

Researchers are evaluating the effects of daily personalized digital reminiscence therapy on patients with early-stage neurocognitive disorders or mild cognitive impairment. The study aims to determine if daily sessions using a digital conversational agent can improve symptoms like apathy and depression, as well as enhance aspects of well-being such as motivation, mood, sleep quality, quality of life, and engagement. It also investigates whether simple reminders through the app can encourage regular use without external help. Participants will use a personalized reminiscence app for 10 to 15 minutes daily over 25 days. A primary caregiver helps personalize the app by sharing family memories, and other relatives may contribute in a private group. The study observes a single group exposed to this digital therapy without a comparison group. During the study, participants complete brief questionnaires at the start and during follow-up visits to assess apathy, depression, sleep quality, and quality of life. Researchers will measure changes in depression and apathy scores at baseline, day 25, and day 50. They will also track session completion and duration. The total participation includes initial use and follow-up assessments to monitor outcomes and engagement.

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders